{
  "orphacode": "42",
  "disease_name": "Medium chain acyl-CoA dehydrogenase deficiency",
  "socioeconomic_impact_studies": [
    {
      "cost": 5831,
      "measure": "Annual mean cost of L-carnitine supplementation and medical consultations per patient",
      "label": "Cost-effectiveness analysis of universal newborn screening for medium chain acyl-CoA dehydrogenase deficiency in France",
      "source": "https://bmcpediatr.biomedcentral.com/articles/10.1186/1471-2431-12-60",
      "country": "France",
      "year": "2012"
    }
  ],
  "score": 7,
  "evidence_level": "Medium-High evidence",
  "justification": "A peer-reviewed economic analysis from a high-income country (France) provided annual treatment cost estimates (â‚¬5,831 per patient for L-carnitine supplementation and consultations), fitting the criteria for medium-high evidence.",
  "metadata": {
    "processing_timestamp": "2025-07-18T19:15:19.201164",
    "run_number": 1,
    "orphacode": "42"
  }
}